Novel Haplotype Indicator for End-Stage Renal Disease Progression among Saudi Patients

Table 1

Frequency of MYH9 E haplotypes compared between stratified groups such as CKD, ESRD, and CAD.

Groups	Haplotype	Frequency	Chi square	value
Control vs. patients	TTTC	0.43	1.075	0.2998
	TTTT	0.27	1.461	0.2268
	GCCT	0.23	0.339	0.5603
	GTTC	0.03	10.979	9 × 10^−4
	TCCT	0.02	0	0.9923
	GTTT	0.01	4.663	0.0308
	TTT	0.7	5.295	0.0214
	GCC	0.24	0.391	0.532
	GTT	0.04	15.934	6.6 × 10^−5
	TCC	0.02	0	0.9896
Control vs. CKD	TTTC	0.43	1.718	0.19
	TTTT	0.28	1.625	0.2024
	GCCT	0.24	2.613	0.106
	GTTC	0.02	9.492	0.0021
	TCCT	0.02	0.07	0.7919
	TTT	0.7	7.108	0.0077
	GCC	0.25	2.584	0.1079
	GTT	0.03	10.934	9 × 10^−4
	TCC	0.02	0.067	0.7954
CAD vs. ESRD	TTTC	0.418	0.009	0.9256
	TTTT	0.269	3.632	0.0567
	GCCT	0.228	0.551	0.4581
	GTTC	0.038	8.051	0.0045
	GTTT	0.028	6.615	0.0101
	TCCT	0.015	0.46	0.4975
Control vs. ESRD	TTTC	0.44	0.294	0.5876
	TTTT	0.27	2.968	0.0849
	GCCT	0.22	0.084	0.7723
	GTTC	0.03	15.431	8.6 × 10^−5
	TCCT	0.02	0.022	0.8828
	GTTT	0.02	14.495	1 × 10^−4
	TTT	0.71	5.181	0.0228
	GCC	0.22	0.06	0.8066
	GTT	0.05	30.498	3.34 × 10^−5
	TCC	0.02	0.021	0.8838
CKD vs. ESRD	TTTC	0.4	0.517	0.4723
	GCCT	0.25	2.542	0.1108
	TTTT	0.23	0.26	0.6104
	GTTC	0.06	0.494	0.4821
	GTTT	0.03	4.217	0.04
	TCCT	0.02	0.008	0.9302
	TTT	0.63	0.082	0.7747
	GCC	0.26	2.442	0.1181
	GTT	0.09	3.329	0.0681
	TCC	0.02	0.007	0.9338
CAD vs. Control	TTTC	0.436	0.533	0.4656
	TTTT	0.298	0.214	0.644
	GCCT	0.228	0.369	0.5435
	TCCT	0.018	0.933	0.3342
	GTTC	0.011	0.154	0.6946